$CBRL stock has now risen 2% today, according to our price data from Polygon. There has been approximately $23,173,917 of trading volume.
It has been the 41st most-searched ticker on Quiver Quantitative over the last day, out of 10,301 total tickers searched.
Here is what we see in our data on $CBRL (you can track the company live on Quiver's $CBRL stock page):
$CBRL Insider Trading Activity
$CBRL insiders have traded $CBRL stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $CBRL stock by insiders over the last 6 months:
- CAPITAL CORP GMT has made 0 purchases and 11 sales selling 508,700 shares for an estimated $13,977,737.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CBRL Hedge Fund Activity
We have seen 125 institutional investors add shares of $CBRL stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EARNEST PARTNERS LLC removed 1,219,507 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $53,731,478
- FRANKLIN RESOURCES INC added 923,409 shares (+13737.1%) to their portfolio in Q3 2025, for an estimated $40,685,400
- BALYASNY ASSET MANAGEMENT L.P. removed 719,226 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $31,689,097
- WOODLINE PARTNERS LP removed 332,790 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,326,813
- BIGLARI CAPITAL CORP. removed 311,775 shares (-34.8%) from their portfolio in Q3 2025, for an estimated $13,736,806
- CITADEL ADVISORS LLC removed 310,624 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $13,686,093
- MARSHALL WACE, LLP removed 254,865 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,229,351
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CBRL Revenue
$CBRL had revenues of $868M in Q4 2025. This is a decrease of -2.95% from the same period in the prior year.
You can track CBRL financials on Quiver Quantitative's CBRL stock page.
$CBRL Congressional Stock Trading
Members of Congress have traded $CBRL stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CBRL stock by members of Congress over the last 6 months:
- REPRESENTATIVE TIM MOORE has traded it 5 times. They made 3 purchases worth up to $200,000 on 12/16, 12/09, 11/20 and 2 sales worth up to $150,000 on 12/10, 11/28.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CBRL Analyst Ratings
Wall Street analysts have issued reports on $CBRL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 12/19/2025
- Citigroup issued a "Sell" rating on 12/10/2025
- Truist Securities issued a "Buy" rating on 12/10/2025
- Argus Research issued a "Buy" rating on 09/29/2025
To track analyst ratings and price targets for $CBRL, check out Quiver Quantitative's $CBRL forecast page.
$CBRL Price Targets
Multiple analysts have issued price targets for $CBRL recently. We have seen 7 analysts offer price targets for $CBRL in the last 6 months, with a median target of $29.0.
Here are some recent targets:
- Sara Senatore from B of A Securities set a target price of $29.0 on 12/19/2025
- Jon Tower from Citigroup set a target price of $20.0 on 12/10/2025
- Anthony Trainor from Wells Fargo set a target price of $30.0 on 12/10/2025
- Dennis Geiger from UBS set a target price of $26.0 on 12/10/2025
- Brian Mullan from Piper Sandler set a target price of $27.0 on 12/10/2025
- Jake Bartlett from Truist Securities set a target price of $45.0 on 12/10/2025
- Christine Dooley from Argus Research set a target price of $50.0 on 09/29/2025
You can track data on $CBRL on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
